NEW YORK, NY / ACCESSWIRE / October 27, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.
MacroGenics, Inc. (NASDAQGS:MGNX)
Lawsuit on behalf of: investors who purchased February 6, 2019 - June 3, 2019
Lead Plaintiff Deadline : November 12, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/macrogenics-inc-loss-form?prid=4053&wire=1
According to the filed complaint, during the class period, MacroGenics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had conducted the progression-free survival (“PFS”) and first interim overall survival (“OS”) analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.
Cadence Bancorporation (NYSE:CADE)
Lawsuit on behalf of: investors who purchased July 23, 2018 - July 22, 2019
Lead Plaintiff Deadline : November 15, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cadence-bankcorporation-loss-form?prid=4053&wire=1
According to the filed complaint, during the class period, Cadence Bancorporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company’s loans posed an increased risk of loss; (3) as a result, the Company was reasonably likely to incur significant losses for certain loans; (4) the Company’s financial results would suffer a material adverse impact; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Infosys Limited (NYSE:INFY)
Lawsuit on behalf of: investors who purchased July 7, 2018 - October 20, 2019
Lead Plaintiff Deadline : December 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/infosys-limited-loss-form?prid=4053&wire=1
According to the filed complaint, during the class period, Infosys Limited made materially false and/or misleading statements and/or failed to disclose that: (1) the Company improperly recognized revenues to inflate short-term profits; (2) Chief Executive Officer Salil Parekh bypassed reviews and approvals for large deals to avoid accounting scrutiny; (3) management pressured the Company’s finance team to hide information from auditors and the Company’s Board of Directors; and (4) as a result of the aforementioned misconduct, Defendants’ statements about Infosys’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com/
SOURCE: Levi & Korsinsky, LLP